Current Assets Alterar Data
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Daiichi Sankyo JPY 1.91T 66.22B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.23B 7.24M 2025-03
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Pfizer USD 45.86B 4.5B 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Tectonic Therapeutic USD 146.86M 15.74M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Sarepta Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.